Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA
K-Number: K190397 · 2019-11-15
Device Summary
Frequently Asked Questions
What is the Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?
Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is a medical device that received FDA 510(k) clearance on 2019-11-15. The listed applicant is Immunalysis Corporation. The 510(k) number is K190397.
When did Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA receive FDA 510(k) clearance?
Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA received FDA 510(k) clearance on 2019-11-15, under 510(k) number K190397.
Who is the listed applicant for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?
The FDA 510(k) record lists Immunalysis Corporation as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA?
The FDA product code for Immunalysis Carisoprodol Metabolite / Meprobamate Urine HEIA is QBK.
Other records listing Immunalysis Corporation as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.